论文部分内容阅读
报告２８例原发性食管腺癌，手术切除率１００％，手术切除死亡率３．６％，经随访１～１５年，１、３、５年生存率分别是７７．８％、４８．１％、２９．６％；按国际ＴＮＭ分期，Ⅱ期、ⅢⅣ期病例５年生存率依次为４６．７％、８．３％，与同期１２２４例食管鳞癌５年生存率，Ⅱ、Ⅲ、Ⅳ期５年生存率（３３．９％，４４．４％，１０．３％）比较，差异无显著性（Ｐ＞０．０５）。对有关因素进行了对比分析。结果显示：食管腺癌与鳞癌一样可有较好的远期疗效。影响疗效的主要因素是肿瘤外侵与否、有无淋巴结转移、病灶分期以及肿瘤的组织学类型和肿瘤的分化程度
Reported 28 cases of primary esophageal adenocarcinoma, surgical resection rate of 100%, surgical resection mortality 3.6%, followed up for 1 to 15 years, 1, 3, and 5-year survival rates were 77.8%, 48.1 %, 29.6%; According to the international TNM stage, the 5-year survival rate of stage II and stage III IV cases was 46.7% and 8.3% respectively, compared with 1224 cases of esophageal squamous cell carcinoma 5-year survival rate, II, III, and the same period. There was no significant difference in the 5-year survival rate (33.9%, 44.4%, 10.3%) in stage IV (P>0.05). The relevant factors were compared and analyzed. The results showed that esophageal adenocarcinoma has the same long-term efficacy as squamous cell carcinoma. The main factors influencing the curative effect are whether the tumor is invaded or not, whether there is lymph node metastasis, the stage of the lesion, and the histological type and differentiation of the tumor.